Protagonist Therapeutics Balance Sheet Analysis

Assets, liabilities, and stockholders equity in billions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Protagonist Therapeutics, Inc. (PTGX) - Annual data in billions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Current Assets
Cash and Cash Equivalents0.100.190.240.120.120.130.13
Short-Term Investments0.320.150.110.200.190.000.00
Cash & Short-Term Investments0.420.340.240.330.310.130.13
Accounts Receivable0.170.010.000.010.000.010.01
Inventory0.000.000.000.000.000.000.00
Other Current Assets0.000.030.030.010.010.020.00
Total Current Assets0.590.360.240.340.320.150.14
Non-Current Assets
Property, Plant & Equipment (Net)0.010.000.000.010.010.010.00
Long-Term Investments0.140.000.000.000.000.000.00
Other Non-Current Assets0.000.000.000.000.000.000.00
Total Non-Current Assets0.150.000.000.010.010.010.00
Total Assets0.740.360.250.350.320.150.14
Current Liabilities
Accounts Payable0.000.000.030.000.000.020.01
Short-Term Debt0.000.000.000.000.000.000.00
Accrued Liabilities0.010.010.020.040.020.000.00
Deferred Revenue0.020.000.000.000.010.000.00
Other Current Liabilities0.020.000.000.000.000.000.00
Total Current Liabilities0.050.020.030.040.040.040.03
Non-Current Liabilities
Long-Term Debt0.010.000.000.000.000.020.00
Other Non-Current Liabilities0.010.000.000.000.000.000.00
Total Non-Current Liabilities0.020.000.000.000.000.040.00
Total Liabilities0.070.020.030.050.040.070.03
Stockholders' Equity
Common Stock0.000.000.000.000.000.000.00
Retained Earnings-0.34-0.62-0.54-0.41-0.28-0.22-0.14
Accumulated Other Comprehensive Income0.000.000.000.000.000.000.00
Additional Paid-in Capital1.020.950.750.710.560.300.25
Shares Outstanding0.060.060.050.050.000.000.00
Total Stockholders' Equity0.680.340.220.300.280.080.11
Total Liabilities & Equity0.740.360.250.350.320.150.14